All stocks Β· ARVEE
AL

Arvee Laboratories (India) Limited

ARVEE NSE Specialty Chemicals Basic Materials

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt,…

ISIN INE006Z01016
Listed 22 Mar 2021
Quarters tracked 13
Filings 11 docs

About

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4Β–amino pyridine, and 2Β–chloroΒ–5Β–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.

Key Metrics

as of Sep 2026
Market Cap182 Cr
P/E44.90
Div Yield0.00 %
Book Valueβ‚Ή30.70
52w Highβ‚Ή291.00
52w Lowβ‚Ή129.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 17.23 10.80 9.78 3.45 7.48 6.45 8.91 12.53 10.60 6.14 7.70 8.91 7.60
Expenses 14.74 9.70 8.15 3.33 7.14 6.23 8.57 11.03 9.06 5.35 7.17 8.22 6.62
Operating Profit 2.49 1.10 1.63 0.12 0.34 0.22 0.34 1.50 1.54 0.79 0.53 0.69 0.98
OPM % 14.45 10.19 16.67 3.48 4.55 3.41 3.82 11.97 14.53 12.87 6.88 7.74 12.89
Other Income 0.18 0.15 0.14 0.23 0.17 0.21 0.19 0.16 0.11 0.21 0.19 0.09 0.09
Depreciation 0.32 0.31 0.30 0.30 0.29 0.27 0.28 0.30 0.31 0.37 0.35 0.42 0.35
Interest 0.06 0.08 0.07 0.04 0.04 0.07 0.05 0.05 0.08 0.05 0.05 0.08 0.07
Profit before tax 2.29 0.86 1.40 0.01 0.18 0.09 0.20 1.31 1.26 0.58 0.32 0.28 0.65
Tax % 26.20 38.37 -30.71 0.00 5.56 22.22 25.00 25.19 25.40 81.03 25.00 25.00 24.62
Net Profit 1.69 0.52 1.83 0.01 0.17 0.07 0.15 0.98 0.94 0.12 0.24 0.21 0.49
EPS in Rs 1.53 0.47 1.66 0.01 0.15 0.06 0.14 0.89 0.85 0.11 0.22 0.19 0.44

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Sales 31.5138.4930.3561.3540.3347.3845.4254.9047.7834.4426.82
Expenses 28.3234.8827.4154.0634.6541.3139.4048.7340.6128.5421.83
Operating Profit 3.193.612.947.295.686.076.026.177.175.904.99
OPM % 10.129.389.6911.8814.0812.8113.2511.2415.0117.1318.61
Other Income 0.680.660.641.350.460.560.350.350.230.510.10
Interest 0.230.250.250.390.370.580.991.633.333.483.07
Depreciation 1.211.151.502.082.322.412.292.352.152.071.49
Profit before tax 2.432.871.836.173.453.643.092.541.920.860.53
Tax % -3.7025.0942.6233.2325.5126.3725.8911.0243.23-81.4066.04
Net Profit 2.532.151.054.122.572.682.302.261.091.550.19
EPS in Rs 2.301.950.953.742.332.432.092.050.991.910.23
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Equity Capital 11.0211.0211.0211.0211.0211.025.515.515.514.054.05
Reserves 22.7720.2418.0917.0412.9210.4213.2510.958.690.15-1.41
Borrowings 1.111.031.001.003.138.883.8712.8716.1524.9925.32
Other Liabilities 8.365.298.459.6311.6110.7311.007.8113.776.497.25
Total Liabilities 43.2637.5838.5638.6938.6841.0533.6337.1444.1235.6835.21
Fixed Assets 16.7215.2712.6712.6813.8413.8113.1812.6514.8816.8813.15
CWIP 0.900.732.621.530.980.971.782.321.180.004.30
Investments 0.000.000.000.000.002.033.091.950.000.000.00
Other Assets 25.6421.5823.2724.4823.8624.2415.5820.2228.0618.8017.76
Total Assets 43.2637.5838.5638.6938.6841.0533.6337.1444.1235.6835.21

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Cash from Operating Activity -0.12-0.213.662.930.681.7110.319.466.024.03
Cash from Investing Activity 0.50-1.32-2.16-1.260.06-0.60-3.08-2.85-1.23-1.40
Cash from Financing Activity -0.16-0.12-0.19-2.42-6.064.52-9.90-4.92-3.78-2.92
Net Cash Flow 0.23-1.641.31-0.75-5.325.63-2.671.681.00-0.29
Free Cash Flow -2.95-2.061.071.47-1.68-0.538.027.964.682.54
CFO/OP % 3.0010.00139.0064.0029.0044.00184.00158.0096.0057.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days 121.0579.6673.4872.94109.7860.7052.4052.66118.2587.1282.61
Inventory Days 228.8180.31159.0242.2993.2491.9680.9642.9099.61104.53155.08
Days Payable 158.6057.72164.4973.30160.12118.08125.6355.84150.0398.14130.73
Cash Conversion Cycle 191.26102.2568.0141.9442.9034.597.7239.7267.8493.50106.96
Working Capital Days 166.92103.5595.9770.4449.96-10.6310.29-6.5230.7930.8430.08
ROCE % 7.929.586.8323.3412.8914.9214.9013.6717.6415.19β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 73.50 73.50 73.50 73.50 73.50 73.50 73.50 73.50 73.50 73.50 73.50 73.50
Public 26.50 26.50 26.50 26.50 26.50 26.50 26.50 26.50 26.50 26.50 26.50 26.50
No. of Shareholders 1,596 1,638 1,861 1,505 1,505 1,576 1,623 1,416 1,480 1,298 1,372 905

Corporate Actions

4 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 20 Sep 2024 β€” β€” β€” Annual General Meeting
Other 15 Sep 2023 β€” β€” β€” Annual General Meeting
Other 28 Jul 2022 β€” β€” β€” Annual General Meeting
Other 16 Sep 2021 β€” β€” β€” Annual General Meeting

Announcements

5 filings
  • Outcome of Board Meeting
    07 Aug 2026 7 Aug - Board approved Q1 FY27 results; postponed scheme of arrangement; set AGM date and notice.
  • Corrigendum
    04 Aug 2026 4 Aug - Corrigendum corrects trading window closure date from 01/04/2026 to 01/07/2026.
  • Trading Window
    27 Jun 2026 27 Jun - Trading window closed from July 1, 2026 until two working days after 30 June results.
  • Disclosure under SEBI Takeover Regulations
    15 Jun 2026 15 Jun - Shalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
  • Outcome of Board Meeting
    19 May 2026 19 May - Arvee Laboratories reported FY26 audited results: revenue Rs 3,151.41 lakh, profit Rs 252.63 lakh, unmodified opinion.

Annual Reports

Credit Ratings

Back to all stocks